University of Washington, Department of Surgery, 1959 NE Pacific St, Box 356410, Seattle, WA 98195, USA.
Pediatrics. 2010 Mar;125(3):e550-8. doi: 10.1542/peds.2009-1713. Epub 2010 Feb 8.
The survival rates after pediatric intestinal transplant according to underlying disease are unknown. The objective of our study was to describe the population of pediatric patients receiving an intestinal transplant and to evaluate survival according to specific disease condition.
Pediatric patients (< or =21 years of age) with intestinal failure meeting criteria for intestinal transplant were included in the study.
A retrospective review of the United Network for Organ Sharing intestinal transplant database (January 1, 1991, to May 16, 2008), including all pediatric transplant centers participating in the United Network for Organ Sharing, was conducted. The main outcome measures were survival and mortality.
Eight hundred fifty-two children received an intestinal transplant (54% male). Median age and weight at the time of transplant were 1 year (interquartile rage: 1-5) and 10.7 kg (interquartile rage: 7.8-21.7). Sixty-nine percent of patients also received a simultaneous liver transplant. The most common diagnoses among patients who received a transplant were gastroschisis (24%), necrotizing enterocolitis (15%), volvulus (14%), other causes of short-gut syndrome (19%), functional bowel syndrome (16%), and Hirschsprung disease (7%). The Kaplan-Meier curves demonstrated variation in patient survival according to diagnosis. Cox regression analysis confirmed a survival difference according to diagnosis (P < .001) and demonstrated a survival advantage for those patients listed with a diagnosis of volvulus (P < .01) compared with the reference gastroschisis. After adjusting for gender, recipient weight, and concomitant liver transplant, children with volvulus had a lower hazard ratio for survival and a lower risk of mortality.
Survival after intestinal transplant was associated with the underlying disease state. The explanation for these findings requires additional investigation into the differences in characteristics of the population of children with intestinal failure.
根据基础疾病,小儿肠移植的存活率尚不清楚。本研究的目的是描述接受肠移植的小儿患者人群,并根据特定疾病状况评估存活率。
患有符合肠移植标准的肠衰竭的小儿患者(<或=21 岁)纳入本研究。
对 1991 年 1 月 1 日至 2008 年 5 月 16 日期间,参与器官共享联合网络(United Network for Organ Sharing)的所有小儿移植中心进行了回顾性审查,包括联合网络肠移植数据库。主要观察指标为存活率和死亡率。
852 例儿童接受了肠移植(54%为男性)。移植时的中位年龄和体重分别为 1 岁(四分位距:1-5)和 10.7kg(四分位距:7.8-21.7)。69%的患者还同时接受了肝移植。接受移植的患者中最常见的诊断为先天性腹裂(24%)、坏死性小肠结肠炎(15%)、肠扭转(14%)、其他短肠综合征(19%)、功能性肠病(16%)和先天性巨结肠(7%)。Kaplan-Meier 曲线显示根据诊断的不同,患者的存活率也存在差异。Cox 回归分析证实诊断对存活率有差异(P<.001),并表明与参考先天性腹裂相比,诊断为肠扭转的患者(P<.01)有生存优势。在调整性别、受体体重和同时性肝移植后,患有肠扭转的儿童的生存风险比更低,死亡风险也更低。
肠移植后的存活率与基础疾病状态相关。这些发现的解释需要进一步研究肠衰竭儿童人群的特征差异。